Ontology highlight
ABSTRACT:
SUBMITTER: Schierle S
PROVIDER: S-EPMC7004070 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
Schierle Simone S Helmstädter Moritz M Schmidt Jurema J Hartmann Markus M Horz Maximiliane M Kaiser Astrid A Weizel Lilia L Heitel Pascal P Proschak Anna A Hernandez-Olmos Victor V Proschak Ewgenij E Merk Daniel D
ChemMedChem 20191119 1
The nuclear farnesoid X receptor (FXR) and the enzyme soluble epoxide hydrolase (sEH) are validated molecular targets to treat metabolic disorders such as non-alcoholic steatohepatitis (NASH). Their simultaneous modulation in vivo has demonstrated a triad of anti-NASH effects and thus may generate synergistic efficacy. Here we report dual FXR activators/sEH inhibitors derived from the anti-asthma drug Zafirlukast. Systematic structural optimization of the scaffold has produced favorable dual pot ...[more]